George Kemble, Executive Chairman at Sagimet Biosciences Inc. (SGMT), sold 14,062 shares at $3.10 ($44K) on 2024-07-19, disclosed to the SEC on 2024-07-23.
Open-market sale of $44k SGMT by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SGMT | SELL | 2026-07-22 | $141K | — | Filing → |
| SGMT | SELL | 2025-11-21 | $580K | — | Filing → |
| SGMT | SELL | 2024-07-25 | $150K | — | Filing → |